EP2844223 - PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 16.12.2016 Database last updated on 22.08.2024 | Most recent event Tooltip | 30.07.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states ALCON INC. Rue Louis-d'Affry 6 1701 Fribourg / CH | [2022/52] |
Former [2019/23] | For all designated states Kala Pharmaceuticals, Inc. 490 Arsenal Way, Suite 120 Watertown, MA 02472 / US | ||
Former [2017/38] | For all designated states Kala Pharmaceuticals, Inc. 100 Beaver Street, Suite 201 Waltham, MA 02453 / US | ||
Former [2015/11] | For all designated states Kala Pharmaceuticals, Inc. 135 Beaver Street, Suite 309 Waltham, MA 02452 / US | Inventor(s) | 01 /
POPOV, Alexey 60 Hope Avenue Waltham, MA 02453 / US | 02 /
ENLOW, Elizabeth, M. 85 Black Bear Drive Unit 1624 Waltham, MA 02451 / US | 03 /
CHEN, Hongming 16 Birch Hill Road Belmont, MA 02478 / US | 04 /
BOURASSA, James Apt. 15, 425 Broadway Somerville, MA 02145 / US | [2020/30] |
Former [2015/11] | 01 /
POPOV, Alexey 60 Hope Avenue Waltham, MA 02453 / US | ||
02 /
ENLOW, Elizabeth, M. 85 Black Bear Drive Unit 1624 Waltham, MA 02451 / US | |||
03 /
CHEN, Hongming 16 Birch Hill Road Belmont, MA 02478 / US | Representative(s) | Murgitroyd & Company 165-169 Scotland Street Glasgow G5 8PL / GB | [N/P] |
Former [2015/11] | Regimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR | Application number, filing date | 13723629.5 | 03.05.2013 | WO2013US39540 | Priority number, date | US201261642261P | 03.05.2012 Original published format: US 201261642261 P | US201261642313P | 03.05.2012 Original published format: US 201261642313 P | US201261738949P | 18.12.2012 Original published format: US 201261738949 P | US201361784701P | 14.03.2013 Original published format: US 201361784701 P | [2015/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013166436 | Date: | 07.11.2013 | Language: | EN | [2013/45] | Type: | A1 Application with search report | No.: | EP2844223 | Date: | 11.03.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.11.2013 takes the place of the publication of the European patent application. | [2015/11] | Search report(s) | International search report - published on: | EP | 07.11.2013 | Classification | IPC: | A61K9/00, A61K47/26, A61K47/34, A61K9/10, A61K31/56 | [2015/11] | CPC: |
A61K9/0048 (EP,US);
A61K9/51 (KR);
A61K31/195 (EP,US);
A61K31/196 (EP,US);
A61K31/407 (EP,US);
A61K31/416 (EP,US);
A61K31/4365 (EP,US);
A61K31/44 (EP,US);
A61K31/4439 (EP,US);
A61K31/506 (EP,US);
A61K31/517 (EP,US);
A61K31/56 (EP,KR,US);
A61K47/26 (EP,US);
A61K47/34 (EP,KR,US);
A61K9/0051 (EP,US);
A61K9/10 (EP,US);
A61K9/16 (KR);
A61K9/5015 (US);
A61K9/5026 (US);
A61K9/5031 (US);
A61K9/5047 (US);
A61P27/02 (EP);
A61P27/06 (EP);
A61P27/14 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/11] | Extension states | BA | 23.10.2014 | ME | 23.10.2014 | Title | German: | PHARMAZEUTISCHE NANOPARTIKEL MIT VERBESSERTEM MUKOSALEM TRANSPORT | [2015/11] | English: | PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT | [2015/11] | French: | NANOPARTICULES PHARMACEUTIQUES À TRANSPORT MUCOSAL AMÉLIORÉ | [2015/11] | Entry into regional phase | 23.10.2014 | National basic fee paid | 23.10.2014 | Designation fee(s) paid | 23.10.2014 | Examination fee paid | Examination procedure | 23.10.2014 | Examination requested [2015/11] | 31.07.2015 | Amendment by applicant (claims and/or description) | 15.12.2016 | Despatch of a communication from the examining division (Time limit: M06) | 15.06.2017 | Reply to a communication from the examining division | 19.09.2018 | Despatch of a communication from the examining division (Time limit: M06) | 27.03.2019 | Reply to a communication from the examining division | 20.08.2020 | Despatch of a communication from the examining division (Time limit: M06) | 18.02.2021 | Reply to a communication from the examining division | 20.08.2021 | Despatch of a communication from the examining division (Time limit: M06) | 21.02.2022 | Reply to a communication from the examining division | 28.03.2024 | Despatch of a communication from the examining division (Time limit: M04) | 29.07.2024 | Reply to a communication from the examining division | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.12.2016 | Fees paid | Renewal fee | 13.05.2015 | Renewal fee patent year 03 | 10.06.2016 | Renewal fee patent year 04 | 10.05.2017 | Renewal fee patent year 05 | 25.05.2018 | Renewal fee patent year 06 | 23.05.2019 | Renewal fee patent year 07 | 22.05.2020 | Renewal fee patent year 08 | 18.05.2021 | Renewal fee patent year 09 | 25.03.2022 | Renewal fee patent year 10 | 14.03.2023 | Renewal fee patent year 11 | 13.03.2024 | Renewal fee patent year 12 | Penalty fee | Additional fee for renewal fee | 31.05.2016 | 04   M06   Fee paid on   10.06.2016 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US2005191359 (GOLDSHTEIN RINA [IL], et al); | [X]WO2006094808 (PHARMASOL GMBH [DE], et al); | [Y]US2007149480 (GHOSH MALAY [US], et al); | [X]US2007178051 (PRUITT JOHN [US], et al); | [Y]US2008194468 (BODOR NICHOLAS S [US]); | [Y]US2010076045 (CASTILLO ERNESTO J [US], et al); | [Y]US2010222308 (ZHANG JING [CN]); | [Y]WO2011106702 (UNIV JOHNS HOPKINS [US], et al); | [Y]WO2012054923 (BIND BIOSCIENCES INC [US], et al); | [YDP]WO2012061703 (UNIV JOHNS HOPKINS [US], et al); | by applicant | WO2012061703 |